PG-033

· Prime Gene Therapeutics Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PG-033, covering 2025-06-10 to 2025-06-10. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Clinical Trial to Evaluate the Single Dose Ascending and Food Effects of PG-033 in Healthy Adults [Phase 1]

See pricing